ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financi...(ttp://www.viropharma.com/docs/Vancocin_p...),Health

Date:10/30/2007

ttp://www.viropharma.com/docs/Vancocin_pi_2007.htm" target="_new">http://www.viropharma.com/docs/Vancocin_pi_2007.htm). ViroPharma currently focuses its drug development activities in viral diseases including cytomegalovirus (CMV) and hepatitis C virus (HCV). For more information on ViroPharma, visit the Company's website at http://www.viropharma.com.

Disclosure Notice

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties, including the Company's financial guidance for 2007. Forward-looking statements provide the Company's current expectations or forecasts of future events. The Company's actual results may vary depending on a variety of factors, including:

-- the development and approval of competitive generic versions of oral

Vancocin, approval of products which are currently marketed for other

indications by other companies or new pharmaceuticals and technological

advances to treat the conditions addressed by Vancocin;

-- fluctuations in wholesaler order patterns and inventory levels;

-- manufacturing, supply or distribution interruptions, including but not

limited to our ability to acquire adequate supplies of Vancocin to meet

demand for the product;

-- changes in prescribing or procedural practices of infectious disease,

gastroenterology and internal medicine doctors, including off-label

prescribing of other products;

-- actions by the FDA, the Internal Revenue Service or other government

regulatory agencies;

-- decreases in the rate of infections for which Vancocin is prescribed;

-- decrease in the sensitivity of the relevant bacteria to Vancocin;

-- changes in terms required by wholesalers, including fee-for-service

contracts;

-- the timing and results of anticipated events in the Company'
'/>"/>

SOURCE ViroPharma Incorporated Copyright©2007 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10
Related medicine news :

1. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
2. Autopsy reports could be valuable and informative
3. China reports declining number of SARS Cases
4. Russia Reports First SARS Case
5. Research reports that c-section deliveries are rising
6. Jharkhand reports 13,000 Malaria cases
7. Uganda Reports Failure To Contain Sleeping Sickness
8. WHO reports 36 million deaths world wide due to chronic diseases
9. Reports of Hantavirus infection in India raise concerns
10. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
11. China Reports Yet Another Bird Flu Case